Reitan Colleen F
CIK 1740730
Transactions on file
24
Open-market buys
2
Win rate (buys)
50%
2 scored
Avg % since filing (buys)
+2.6%
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-05 | 2026-06-04 | MYGN MYRIAD GENETICS INC | Director | Grant | 59,701 | $0.00 | — | open → |
| 2026-05-22 | 2026-05-20 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Director | Grant | 671 | $0.00 | — | open → |
| 2025-05-12 | 2025-05-08 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Director | Grant | 775 | $0.00 | — | open → |
| 2025-05-12 | 2025-04-16 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Director | Sale | 36 | $8.4K | +29.5% | open → |
| 2025-05-12 | 2024-10-17 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Director | Buy | 4 | $1.2K | -0.3% | open → |
| 2025-05-12 | 2024-08-29 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Director | Buy | 32 | $9.2K | +5.5% | open → |
| 2025-06-06 | 2025-06-05 | MYGN MYRIAD GENETICS INC | Director | Grant | 49,796 | $0.00 | — | open → |
| 2025-09-11 | 2025-09-09 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Director | Sale | 951 | $451.6K | -36.5% | open → |
| 2025-09-11 | 2025-09-09 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Director | Sale | 838 | $397.4K | -36.4% | open → |
| 2025-09-11 | 2025-09-09 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Director | Sale | 823 | $389.1K | -36.2% | open → |
| 2025-09-11 | 2025-09-09 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Director | Sale | 222 | $104.6K | -36.0% | open → |
| 2025-09-11 | 2025-09-09 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Director | Sale | 799 | $371.0K | -35.0% | open → |
| 2025-09-11 | 2025-09-09 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Director | Sale | 1,652 | $764.9K | -34.8% | open → |
| 2025-09-11 | 2025-09-09 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Director | Sale | 2,290 | $1.06M | -34.7% | open → |
| 2025-09-11 | 2025-09-09 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Director | Sale | 473 | $217.9K | -34.5% | open → |
| 2025-09-11 | 2025-09-09 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Director | Sale | 1,403 | $645.0K | -34.4% | open → |
| 2025-09-11 | 2025-09-09 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Director | Sale | 1,888 | $866.3K | -34.3% | open → |
| 2025-09-11 | 2025-09-09 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Director | Sale | 25 | $12.0K | -37.3% | open → |
| 2025-09-11 | 2025-09-09 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Director | Sale | 1,386 | $664.7K | -37.1% | open → |
| 2025-09-11 | 2025-09-09 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Director | Sale | 1,450 | $694.1K | -37.0% | open → |
| 2025-09-11 | 2025-09-09 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Director | Sale | 1,645 | $752.5K | -34.1% | open → |
| 2025-09-11 | 2025-09-09 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Director | Sale | 972 | $463.0K | -36.7% | open → |
| 2025-09-11 | 2025-09-09 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Director | Exer. | 18,000 | $1.81M | +199.7% | open → |
| 2025-09-11 | 2025-09-09 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Director | Sale | 1,183 | $564.8K | -36.8% | open → |
